The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is ...

The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is ...

Four drugs listed as products with the greatest risk of supply disruption and vulnerability after a U.S. drugmaker closed in February are on back order. The U.S. now has no supply of four others.

AcelRx Pharmaceuticals has announced the sale of its drug DSUVIA (sufentanil sublingual tablet) to Alora Pharmaceuticals.

Maternal satisfaction were improved due to the fewer adverse drug reactions associated with intrathecal sufentanil that can be disconcerting for subjects. The limitation of this study was that ...

Feb 26, 2023 (Heraldkeepers) -- New Jersey, United States,- Our report on the Sufentanil API market provides a comprehensive and in-depth analysis of the Sufentanil API market. The report assesses ...

The cause, in a nutshell, is fentanyl, the potent synthetic opioid that has shouldered aside cocaine and oxycontin and heroin ...

Divestment of DSUVIA® to Alora Pharmaceuticals expected to close the week of April 3, 2023AcelRx advancing its proprietary ...

Drug Name : Sufentanil Citrate Injection Sufentanil Citrate Injection(Sufenta) generic is a narcotic analgesic, prescribed for inducing anesthesia during surgery.

Ropivacaine combined with sufentanil were used in all subjects. The labor time, visual analogue scale (VAS), Apgar score of newborn, adverse pregnancy outcomes and adverse drug reactions were ...

Divestment of DSUVIA® to Alora Pharmaceuticals expected to close the week of April 3, 2023 AcelRx advancing its proprietary Niyad nafamastat program with FDA Breakthrough designation in line with a st ...